MedTrace Logo

Periodontal Disease and Cardiovascular Disease

NCT00763165 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 438

Last updated 2008-10-02

No results posted yet for this study

Summary

To access the influence of triclosan dentifrice on the progression of periodontal disease in patients with coronary heart disease.

Conditions

  • Periodontal Diseases

Interventions

DRUG

Triclosan

Brush twice daily

DRUG

Fluoride

Brush twice daily

DRUG

Fluoride

Brush twice daily

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Principal Investigators

  • Gregory Seymour, BDS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-11-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00763165 on ClinicalTrials.gov